V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004191 | 290006433 | null | 69 | Not known (9) | 2017-07-16 | 2017-07-18 | Hydroxycarbamide | 2 | N | 290020722 | CAPECITABINE + GEMCITABINE |
| 290004192 | 290006433 | 1.57 | 64.9 | Palliative (P) | 2014-11-01 | 2014-11-03 | Gemcitabine + Capecitabine | 2 | N | 290020722 | CETUXIMAB + RT |
| 290004193 | 290003093 | 1.51 | 47 | Palliative (P) | 2017-09-09 | 2017-09-20 | Carbo F | null | N | 290020725 | CARBOPLATIN + ETOPOSIDE |
| 290004194 | 290003094 | 1.7 | 76.6 | Adjuvant (A) | 2016-07-25 | 2016-08-19 | CARBOPLATIN + RT | 02 | N | 290020726 | OCTREOTIDE |
| 290004195 | 290003095 | 1.54 | 58.9 | Neo-adjuvant (N) | 2013-11-20 | 2013-11-27 | Cisplatin + Vinorelbine (IV) | N | N | 290020727 | IVA |
| 290004196 | 290006434 | 1.55 | null | Palliative (P) | 2018-11-06 | 2018-11-27 | LANREOTIDE | null | N | 290020729 | CISPLATIN + FLUOROURACIL |
| 290004197 | 290003096 | 1.67 | 57.8 | Neo-adjuvant (N) | 2016-02-07 | 2016-02-18 | LANREOTIDE | N | N | 290020731 | TRIAL |
| 290004198 | 290003097 | null | null | Adjuvant (A) | 2017-01-04 | 2017-04-07 | ECX | N | N | 290020733 | TRIAL |
| 290004199 | 290003097 | 0 | 57 | Neo-adjuvant (N) | 2016-04-17 | 2016-05-30 | CARBOPLATIN + GEMCITABINE | N | Y | 290020733 | CAPECITABINE |
| 290004200 | 290003097 | 1.61 | 72 | Neo-adjuvant (N) | 2013-09-09 | 2013-09-09 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020733 | BEVACIZUMAB |
| 290004201 | 290003098 | 1.63 | 50 | Not known (9) | 2016-06-17 | 2016-07-10 | Fluorouricil + Folonic Acid (MdG) | N | Y | 290020741 | GEMCARBO |
| 290004202 | 290003099 | 1.62 | 58.999 | Palliative (P) | null | 2016-02-05 | ECX | N | N | 290020744 | KESTREL TRIAL |
| 290004203 | 290003100 | 1.63 | 57.1 | Curative (C) | 2015-09-02 | 2015-09-10 | Capecitabine 35days + RT | Y | Y | 290020746 | CAPECITABINE + RT |
| 290004204 | 290003101 | 1.68 | null | Palliative (P) | 2013-08-08 | 2013-08-12 | CHOP R - 21 days | null | N | 290020748 | INTERFERON |
| 290004205 | 290006436 | 1.63 | 61.7 | null | 2017-07-19 | 2017-07-19 | Cisplatin + Fluorouracil + RT 5day | 02 | null | 290020754 | CARBOPLATIN + PEMETREXED |
| 290004206 | 290003102 | 1.68 | 77.4 | Palliative (P) | 2014-10-23 | 2014-10-25 | Folfirinox | N | N | 290020756 | Y-90 |
| 290004207 | 290003103 | null | 71.5 | Palliative (P) | 2016-03-11 | 2016-03-11 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 290020757 | CARBOPLATIN + ETOPOSIDE |
| 290004208 | 290003104 | 1.7 | 73.3 | Neo-adjuvant (N) | 2016-07-18 | 2016-07-18 | TCF | 2 | N | 290020758 | RITUXIMAB |
| 290004209 | 290003105 | null | null | Curative (C) | 2017-02-09 | 2017-02-09 | PEMBROLIZUMAB | null | Y | 290020760 | CAPECITABINE |
| 290004210 | 290003106 | 1.73 | 46.4 | Neo-adjuvant (N) | 2017-11-24 | 2017-11-24 | Cisplatin +Fluorouracil (3 wk) | 2 | null | 290020761 | FLUOROURACIL |
| 290004211 | 290003107 | 1.86 | 51.8 | Palliative (P) | 2014-01-16 | 2014-01-17 | Capecitabine | N | N | 290020763 | TEMOZOLOMIDE |
| 290004212 | 290003107 | 1.68 | 65.7 | Palliative (P) | 2018-03-09 | 2018-03-13 | CARBOPLATIN + RT | 02 | N | 290020763 | LANREOTIDE |
| 290004213 | 290003108 | 1.81 | 92.7 | Palliative (P) | 2018-01-16 | 2018-01-16 | Trial Unspecified | 02 | N | 290020766 | CISPLATIN + FLUOROURACIL |
| 290004214 | 290003109 | 1.54 | 74.5 | Palliative (P) | 2015-11-05 | 2015-11-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 290020769 | DOXORUBICIN + OLARATUMAB |
| 290004215 | 290003110 | 1.57 | 46.4 | Palliative (P) | 2017-01-15 | 2017-02-10 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 290020770 | CAPECITABINE |
| 290004216 | 290003111 | 1.57 | 0 | Curative (C) | 2016-02-16 | 2016-03-07 | CISPLATIN + GEMCITABINE | N | Y | 290020772 | CAPECITABINE |
| 290004217 | 290003112 | null | 44.1 | Palliative (P) | 2017-01-28 | 2017-02-09 | ECX | 02 | N | 290020774 | CAPECITABINE + RT |
| 290004218 | 290003113 | 1.55 | null | Curative (C) | 2016-06-05 | 2016-06-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 290020776 | CETUXIMAB + CISPLATIN + FU |
| 290004219 | 290003114 | 1.76 | 61.6 | Palliative (P) | 2017-11-19 | 2017-11-26 | FLUOROURACIL | 02 | null | 290020777 | DHAP - R |
| 290004220 | 290003115 | 1.56 | null | Curative (C) | 2016-07-28 | 2016-07-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 290020780 | STREPTOZOCIN + MDG |
| 290004221 | 290003115 | 1.72 | 102.55 | Adjuvant (A) | 2013-10-28 | 2013-11-11 | MITOMYCIN | N | N | 290020780 | FLUOROURACIL |
| 290004223 | 290003117 | 1.71 | 75.1 | Curative (C) | 2013-04-17 | 2013-05-15 | CISPLATIN + FLUOROURACIL | N | Y | 290020784 | CARBOPLATIN + RT |
| 290004224 | 290003118 | 1.59 | 48.6 | Adjuvant (A) | 2013-08-25 | 2013-08-25 | Capecitabine + Cisplatin + RT | 02 | N | 290020785 | PACLITAXEL |
| 290004225 | 290003118 | 1.56 | null | Palliative (P) | 2016-12-20 | 2016-12-20 | CAPECITABINE + GEMCITABINE | 02 | null | 290020785 | FLUOROURACIL |
| 290004226 | 290003118 | 1.81 | 78.7 | Palliative (P) | 2017-06-13 | 2017-06-17 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | N | 290020785 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004227 | 290003119 | null | 72.3 | Neo-adjuvant (N) | 2017-05-04 | 2017-05-11 | EOF | N | N | 290020789 | CARBOPLATIN |
| 290004228 | 290003119 | null | null | Palliative (P) | 2013-09-29 | 2013-09-29 | Cisplatin +Fluorouracil (2 wk) | 02 | N | 290020789 | CAPECITABINE + RT |
| 290004229 | 290003120 | 1.59 | 67.2 | Neo-adjuvant (N) | 2015-02-07 | 2015-02-24 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 290020793 | IRINOTECAN + MDG |
| 290004230 | 290003120 | 1.53 | 66.8 | Palliative (P) | 2017-01-07 | 2017-01-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020793 | CARBOPLATIN + ETOPOSIDE |
| 290004231 | 290003120 | 1.62 | 78.1 | Palliative (P) | 2018-01-19 | 2018-02-06 | Fluorouracil + Folinic + RT Bossett | null | N | 290020793 | GEMCITABINE |
| 290004232 | 290008178 | 1.61 | null | Palliative (P) | 2017-04-02 | 2017-04-15 | Capecitabine 35days + RT | N | N | 290020796 | CISPLATIN + FLUOROURACIL |
| 290004233 | 290003121 | 1.98 | 74.3 | Curative (C) | 2017-11-13 | 2017-12-06 | LANREOTIDE | 02 | Y | 290020797 | ECX |
| 290004234 | 290006442 | null | 68.4 | Palliative (P) | 2014-07-15 | 2014-07-28 | CISPLATIN + FLUOROURACIL | 02 | null | 290020798 | CARBO + FLUOROURACIL |
| 290004235 | 290007721 | 1.78 | null | Not known (9) | 2016-11-03 | 2016-11-24 | Gemcitabine weekly | N | N | 290020799 | PEMBROLIZUMAB |
| 290004236 | 290003122 | 1.56 | 61.1 | Neo-adjuvant (N) | 2014-07-07 | 2014-07-08 | LANREOTIDE | N | N | 290020806 | CISPLATIN + FLUOROURACIL |
| 290004237 | 290003122 | 1.46 | 56.4 | Disease modification (D) | 2013-08-01 | 2013-08-26 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020806 | PANITUMUMAB |
| 290004238 | 290003123 | 1.73 | 104.2 | Neo-adjuvant (N) | null | 2018-01-23 | Capecitabine 35days + RT | N | N | 290020809 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290004239 | 290003123 | 1.7 | 78 | Not known (9) | 2015-07-27 | 2015-07-30 | Sunitinib | 01 | N | 290020809 | IPILIMUMAB |
| 290004240 | 290007722 | 1.75 | 84 | Neo-adjuvant (N) | 2013-12-15 | 2013-12-29 | Carboplatin AUC 2 - 5 | N | N | 290020812 | CAPECITABINE + RT |
| 290004241 | 290003124 | 1.64 | 54 | Neo-adjuvant (N) | 2015-07-31 | 2015-07-31 | ECX | N | N | 290020816 | CETUXIMAB + IRINOTECAN + MDG |